Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free RTW Stock Alerts

RTW Biotech Opportunities (RTW) Competitors

RTW Biotech Opportunities logo
GBX 2.46 +0.01 (+0.41%)
As of 11:46 AM Eastern
Compare

RTW vs. SDV, VSL, RSE, CIP, and PGIT

Should you buy RTW Biotech Opportunities stock or one of its competitors? MarketBeat compares RTW Biotech Opportunities with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with RTW Biotech Opportunities include Chelverton UK Dividend Trust (SDV), VPC Specialty Lending Investments (VSL), Riverstone Energy (RSE), CIP Merchant Capital (CIP), and Premier Global Infrastructure Trust PLC (PGIT.L) (PGIT).

How does RTW Biotech Opportunities compare to Chelverton UK Dividend Trust?

Chelverton UK Dividend Trust (LON:SDV) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

1.9% of Chelverton UK Dividend Trust shares are owned by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 1.5% of Chelverton UK Dividend Trust shares are owned by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

RTW Biotech Opportunities has a net margin of 158.61% compared to Chelverton UK Dividend Trust's net margin of 86.83%. RTW Biotech Opportunities' return on equity of 36.01% beat Chelverton UK Dividend Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Chelverton UK Dividend Trust86.83% 15.15% 0.90%
RTW Biotech Opportunities 158.61%36.01%-0.47%

RTW Biotech Opportunities has higher revenue and earnings than Chelverton UK Dividend Trust. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Chelverton UK Dividend Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chelverton UK Dividend Trust£5.33M6.03£8.87M£21.906.53
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

In the previous week, Chelverton UK Dividend Trust's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Chelverton UK Dividend Trust Neutral
RTW Biotech Opportunities Neutral

Chelverton UK Dividend Trust has a beta of 0.7166866, suggesting that its share price is 28% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.763, suggesting that its share price is 24% less volatile than the broader market.

Summary

RTW Biotech Opportunities beats Chelverton UK Dividend Trust on 7 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to VPC Specialty Lending Investments?

VPC Specialty Lending Investments (LON:VSL) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

22.1% of VPC Specialty Lending Investments shares are owned by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 0.3% of VPC Specialty Lending Investments shares are owned by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, VPC Specialty Lending Investments' average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
VPC Specialty Lending Investments Neutral
RTW Biotech Opportunities Neutral

RTW Biotech Opportunities has a net margin of 158.61% compared to VPC Specialty Lending Investments' net margin of 108.11%. RTW Biotech Opportunities' return on equity of 36.01% beat VPC Specialty Lending Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
VPC Specialty Lending Investments108.11% -46.94% -3.93%
RTW Biotech Opportunities 158.61%36.01%-0.47%

VPC Specialty Lending Investments has a beta of 0.30362844, meaning that its stock price is 70% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.763, meaning that its stock price is 24% less volatile than the broader market.

RTW Biotech Opportunities has higher revenue and earnings than VPC Specialty Lending Investments. VPC Specialty Lending Investments is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VPC Specialty Lending Investments-£31.41M-1.00-£31.27M-£11.87N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

Summary

RTW Biotech Opportunities beats VPC Specialty Lending Investments on 10 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Riverstone Energy?

Riverstone Energy (LON:RSE) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

In the previous week, Riverstone Energy's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Riverstone Energy Neutral
RTW Biotech Opportunities Neutral

Riverstone Energy has a beta of 0.127, suggesting that its stock price is 87% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.763, suggesting that its stock price is 24% less volatile than the broader market.

8.2% of Riverstone Energy shares are owned by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 66.9% of Riverstone Energy shares are owned by company insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

RTW Biotech Opportunities has higher revenue and earnings than Riverstone Energy. Riverstone Energy is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Riverstone Energy£31.65M0.94£78.63M-£2.17N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

RTW Biotech Opportunities has a net margin of 158.61% compared to Riverstone Energy's net margin of -0.58%. RTW Biotech Opportunities' return on equity of 36.01% beat Riverstone Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Riverstone Energy-0.58% -0.20% -0.22%
RTW Biotech Opportunities 158.61%36.01%-0.47%

Summary

RTW Biotech Opportunities beats Riverstone Energy on 7 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to CIP Merchant Capital?

CIP Merchant Capital (LON:CIP) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, CIP Merchant Capital's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
CIP Merchant Capital Neutral
RTW Biotech Opportunities Neutral

RTW Biotech Opportunities has higher revenue and earnings than CIP Merchant Capital. CIP Merchant Capital is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CIP Merchant Capital£8.87M0.00N/A£13.70N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

RTW Biotech Opportunities has a net margin of 158.61% compared to CIP Merchant Capital's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat CIP Merchant Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
CIP Merchant CapitalN/A N/A N/A
RTW Biotech Opportunities 158.61%36.01%-0.47%

Summary

RTW Biotech Opportunities beats CIP Merchant Capital on 6 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Premier Global Infrastructure Trust PLC (PGIT.L)?

Premier Global Infrastructure Trust PLC (PGIT.L) (LON:PGIT) and RTW Biotech Opportunities (LON:RTW) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

RTW Biotech Opportunities has a net margin of 158.61% compared to Premier Global Infrastructure Trust PLC (PGIT.L)'s net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat Premier Global Infrastructure Trust PLC (PGIT.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Premier Global Infrastructure Trust PLC (PGIT.L)N/A N/A N/A
RTW Biotech Opportunities 158.61%36.01%-0.47%

In the previous week, Premier Global Infrastructure Trust PLC (PGIT.L)'s average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Premier Global Infrastructure Trust PLC (PGIT.L) Neutral
RTW Biotech Opportunities Neutral

RTW Biotech Opportunities has higher revenue and earnings than Premier Global Infrastructure Trust PLC (PGIT.L). Premier Global Infrastructure Trust PLC (PGIT.L) is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier Global Infrastructure Trust PLC (PGIT.L)-£2.54M0.00N/A-£40.70N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

Summary

RTW Biotech Opportunities beats Premier Global Infrastructure Trust PLC (PGIT.L) on 7 of the 8 factors compared between the two stocks.

Get RTW Biotech Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RTW vs. The Competition

Export
MetricRTW Biotech OpportunitiesCapital Markets IndustryFinance SectorLON Exchange
Market Cap£7.94M£5.61B£14.06B£3.02B
Dividend YieldN/A7.50%5.95%6.13%
P/E Ratio0.0437.1628.97368.30
Price / Sales0.031,111.99468.2083,642.08
Price / Cash0.3248.0429.9527.89
Price / Book0.013.743.747.07
Net Income£14.09B£417.17M£1.31B£5.89B
7 Day Performance2.07%1.13%0.91%0.54%
1 Month Performance1.23%-0.15%1.29%0.25%
1 Year Performance86.65%7.20%13.80%64.64%

RTW Biotech Opportunities Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RTW
RTW Biotech Opportunities
N/AGBX 2.46
+0.4%		N/A+85.6%£7.94M£250.89M0.044,971
SDV
Chelverton UK Dividend Trust
N/AGBX 139.50
+0.4%		N/A-2.6%£31.32M£5.33M6.37N/A
VSL
VPC Specialty Lending Investments
N/AGBX 10.76
+0.1%		N/A-28.2%£29.95M-£31.41MN/AN/A
RSE
Riverstone Energy
N/AGBX 586
+4.6%		N/A-31.1%£28.26M£31.65MN/AN/A
CIP
CIP Merchant Capital
N/AN/AN/AN/A£27.50M£8.87M3.65N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:RTW) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
"Second Wave” Hitting Iran Soon? Wall Street Issues Warning
Analysts at Goldman Sachs and Morgan Stanley are warning that a quiet domestic threat - unrelated to overseas ...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
1 Stock to Own by July 31st
A scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...
Chaikin Analytics | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Now that SpaceX is public, buy this ticker (no, not SpaceX or Tesla)
The SpaceX IPO wasn't the big trade - according to Larry Benedict, founder of The Opportunistic Trader, it was...
Brownstone Research | Sponsoredtc pixel
This loan shouldn't be possible
On May 21, 2026, a federal board unanimously approved a roughly 3 billion dollar loan to a single American min...
Behind the Markets | Sponsoredtc pixel